ESPERION THERAPEUTICS INC (ESPR:NASDAQ)
$3.18 -0.01 (-0.3135%)
Analysed ESPERION THERAPEUTICS INC (ESPR:NASDAQ) News Sources
Summit’s ‘self-inflicted’ stumble; Esperion’s take-private deal
01-05-2026
biopharmadive.com
ARCHIMED to acquire Esperion Therapeutics in $1.1 billion deal
01-05-2026
qz.com
Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026
13-05-2026
yahoo.com
ESPR Stock Surges 44% in a Month: Here's What You Need to Know
14-05-2026
yahoo.com
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
14-05-2026
yahoo.com
Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026
26-05-2026
yahoo.com
Catalyst (CPRX) Up 0.6% Since Last Earnings Report: Can It Continue?
10-06-2026
yahoo.com
Why Is Altimmune (ALT) Down 11.3% Since Last Earnings Report?
12-06-2026
yahoo.com
Esperion Therapeutics (ESPR) Stock Fair Value Moves Lower After Analyst Downgrades
23-06-2026
yahoo.com
Esperion Therapeutics Clears Key Hurdle as Stockholders Approve Essence Merger
10-07-2026
marketbeat.com
What is the current price of ESPERION THERAPEUTICS INC (ESPR:NASDAQ)?
The current price of ESPERION THERAPEUTICS INC (ESPR:NASDAQ) is $3.18.
ESPERION THERAPEUTICS INC (ESPR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ESPERION THERAPEUTICS INC (ESPR:NASDAQ) since the previous trading day is $-0.01.
ESPERION THERAPEUTICS INC (ESPR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ESPERION THERAPEUTICS INC (ESPR:NASDAQ) since the previous trading day is -0.3135%.
What is the most recent average sentiment score for ESPERION THERAPEUTICS INC (ESPR:NASDAQ)?
The most recent average sentiment score for ESPERION THERAPEUTICS INC (ESPR:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for ESPERION THERAPEUTICS INC (ESPR:NASDAQ)?
The most recent sentiment for ESPERION THERAPEUTICS INC (ESPR:NASDAQ) is .
SEC-8K** Filing Available For ESPERION THERAPEUTICS INC (ESPR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.